TY - JOUR
T1 - Memantine prevents acute radiation-induced toxicities at hippocampal excitatory synapses
AU - Duman, Joseph G.
AU - Dinh, Jeffrey
AU - Zhou, Wei
AU - Cham, Henry
AU - Mavratsas, Vasilis C.
AU - Pavešković, Matea
AU - Mulherkar, Shalaka
AU - McGovern, Susan L.
AU - Tolias, Kimberley F.
AU - Grosshans, David R.
N1 - Funding Information:
This work was supported by the American Cancer Society (IRG-08-061-01), the Cancer Prevention Research Institute of Texas (RP140430, NIH CA208535; to D.R.G.), NIH MH086119 and NIH K01MH086119 (to J.G.D.), and NIH NS062829 (to K.F.T.).
Publisher Copyright:
© 2017 The Author(s).
PY - 2018/4/9
Y1 - 2018/4/9
N2 - Background Memantine has shown clinical utility in preventing radiation-induced cognitive impairment, but the mechanisms underlying its protective effects remain unknown. We hypothesized that abnormal glutamate signaling causes radiation-induced abnormalities in neuronal structure and that memantine prevents synaptic toxicity. Methods Hippocampal cultures expressing enhanced green fluorescent protein were irradiated or sham-treated and their dendritic spine morphology assessed at acute (minutes) and later (days) times using high-resolution confocal microscopy. Excitatory synapses, defined by co-localization of the pre-and postsynaptic markers vesicular glutamate transporter 1 and postsynaptic density protein 95, were also analyzed. Neurons were pretreated with vehicle, the N-methyl-d-aspartate-type glutamate receptor antagonist memantine, or the glutamate scavenger glutamate pyruvate transaminase to assess glutamate signaling. For animal studies, Thy-1-YFP mice were treated with whole-brain radiotherapy or sham with or without memantine. Results Unlike previously reported long-term losses of dendritic spines, we found that the acute response to radiation is an initial increase in spines and excitatory synapses followed by a decrease in spine/synapse density with altered spine dynamics. Memantine pre-administration prevented this radiation-induced synaptic remodeling. Conclusion These results demonstrate that radiation causes rapid, dynamic changes in synaptic structural plasticity, implicate abnormal glutamate signaling in cognitive dysfunction following brain irradiation, and describe a protective mechanism of memantine.
AB - Background Memantine has shown clinical utility in preventing radiation-induced cognitive impairment, but the mechanisms underlying its protective effects remain unknown. We hypothesized that abnormal glutamate signaling causes radiation-induced abnormalities in neuronal structure and that memantine prevents synaptic toxicity. Methods Hippocampal cultures expressing enhanced green fluorescent protein were irradiated or sham-treated and their dendritic spine morphology assessed at acute (minutes) and later (days) times using high-resolution confocal microscopy. Excitatory synapses, defined by co-localization of the pre-and postsynaptic markers vesicular glutamate transporter 1 and postsynaptic density protein 95, were also analyzed. Neurons were pretreated with vehicle, the N-methyl-d-aspartate-type glutamate receptor antagonist memantine, or the glutamate scavenger glutamate pyruvate transaminase to assess glutamate signaling. For animal studies, Thy-1-YFP mice were treated with whole-brain radiotherapy or sham with or without memantine. Results Unlike previously reported long-term losses of dendritic spines, we found that the acute response to radiation is an initial increase in spines and excitatory synapses followed by a decrease in spine/synapse density with altered spine dynamics. Memantine pre-administration prevented this radiation-induced synaptic remodeling. Conclusion These results demonstrate that radiation causes rapid, dynamic changes in synaptic structural plasticity, implicate abnormal glutamate signaling in cognitive dysfunction following brain irradiation, and describe a protective mechanism of memantine.
KW - memantine
KW - radiation
KW - synapse
UR - http://www.scopus.com/inward/record.url?scp=85045132184&partnerID=8YFLogxK
U2 - 10.1093/neuonc/nox203
DO - 10.1093/neuonc/nox203
M3 - Article
C2 - 29112734
AN - SCOPUS:85045132184
SN - 1522-8517
VL - 20
SP - 655
EP - 665
JO - Neuro-Oncology
JF - Neuro-Oncology
IS - 5
ER -